Subcutaneous Emphysema: Clinical Trials

1 trial for Subcutaneous Emphysema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Subcutaneous Emphysema: new trials by email Literature Review of Subcutaneous Emphysema trials Research Report on Subcutaneous Emphysema

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery
Alpha 1-Antitrypsin - Post Cardiac Surgery Systemic Inflammatory Response
Phase 1 / Phase 2UnknownSoroka University Medical Center202014-07-012014-07-16

Narrower conditions

Inflammation (1)  ·  alpha 1-Antitrypsin Deficiency (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Emphysema (1)  ·  Genetic Diseases, Inborn (1)  ·  Liver Diseases (1)  ·  Lung Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Diseases (1)

Interventions

alpha 1-Antitrypsin (1)

Sponsors

Soroka University Medical Center (1)